title: Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
abstract: The present study illustrates characteristic features of histopathology in the 3 non-leukemic, Ph-negative groups of chronic myeloproliferative diseases (CMPD). Attention is paid to the final outcome of CMPD, especially its transformation into acute leukemias and the occurrence of myelofibrosis from bone marrow biopsies (BMB) in a total of 1,716 CMPD patients. Essential thrombocythemia (ET), polycythemia vera (P. vera), and chronic megakaryocytic granulocytic myelosis (CMGM) can readily be distinguished by histopathology from BMB in the great majority of patients without regarding laboratory data, leaving a compartment of about 12% unclassifiable cases. Histologic patterns of staging are the increase in number and pleomorphism of megakaryocytes (MK), increase in number and density of reticulin fibers and collagen fibrosis, and excess of blasts. These 3 criteria are each graded from 0 to 3 in every biopsy. From these, a staging results by means of the histology of BMB in each of the Ph-negative CMPD. This staging provides a classification by defined criteria which permits comparative studies, the possibility of monitoring the individual patients by follow-up histology, and offers a baseline for reliable evaluation of results from therapy protocols.
authors.affiliation: Department of Pathology, Hannover Medical School, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Georgii
authors.forename: T
authors.initials: T
authors.lastname: Buhr
authors.forename: G
authors.initials: G
authors.lastname: Buesche
authors.forename: A
authors.initials: A
authors.lastname: Kreft
authors.forename: H
authors.initials: H
authors.lastname: Choritz
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001752:Blast Crisis / Q000453:epidemiology / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology*; D001856:Bone Marrow Examination; D002648:Child; D018450:Disease Progression; D005260:Female; D006801:Humans; D007938:Leukemia / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000145:classification / Q000188:drug therapy / Q000473:pathology*; D011087:Polycythemia Vera / Q000473:pathology; D055728:Primary Myelofibrosis / Q000473:pathology; D013920:Thrombocythemia, Essential / Q000473:pathology